Reddys

Dr. Reddy’s US generics enterprise drags Q1 earnings, eyes weight-loss drug launch in 87 international locations

by

[ad_1] Dr Reddy’s Laboratories Ltd’s US generics enterprise slumped within the June quarter because it confronted value erosion in key merchandise like gRevlimid used to deal with most cancers. US generics income declined 11% year-on-year and 4% sequentially to ₹3,412 crore within the first quarter of FY26, based on earnings introduced on Wednesday. The enterprise … Read more

Solar Pharma, Lupin, Dr Reddys recall merchandise in US market

by

[ad_1] New Delhi, Home drug majors Solar Pharma, Lupin and Dr Reddy’s Laboratories are recalling medicine within the US market as a consequence of manufacturing points and product combine up, based on the US well being regulator. As per the most recent Enforcement Report of US Meals and Drug Administration , the Mumbai-headquartered Solar Pharmaceutical … Read more